Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases
The invention provides combinations comprising a MEK inhibitor (such as GDC-0973 or GDC-0623), or a pharmaceutical ly acceptable salt thereof and an ERK inhibitor (such as GDC-0994). The combinations are particularly useful for treating hyperproliferative disorders, such as cancer.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.02.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention provides combinations comprising a MEK inhibitor (such as GDC-0973 or GDC-0623), or a pharmaceutical ly acceptable salt thereof and an ERK inhibitor (such as GDC-0994). The combinations are particularly useful for treating hyperproliferative disorders, such as cancer. |
---|---|
AbstractList | The invention provides combinations comprising a MEK inhibitor (such as GDC-0973 or GDC-0623), or a pharmaceutical ly acceptable salt thereof and an ERK inhibitor (such as GDC-0994). The combinations are particularly useful for treating hyperproliferative disorders, such as cancer. |
Author | MOFFAT, JOHN BELVIN, MARCIA MERCHANT, MARK |
Author_xml | – fullname: MOFFAT, JOHN – fullname: MERCHANT, MARK – fullname: BELVIN, MARCIA |
BookMark | eNqNjLsKwkAQRbfQwtc_jB8gxGdqkYggNhKxDJNklgwkM8vuIvj3RrSwtDhcONx7x2YgKjQyfAsEagGh0q5kwcgqH3HJzsDScMlRPaDUPZBdf6XtiZ4wdiTxvWqejrzz2rIl3389CGoOhIHC1AwttoFm35yY-THLD6cFOS0oOKxIKBb5fZUsd8l2k6b79T-dF9XYQaQ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | TW201605477A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_TW201605477A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:15:09 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_TW201605477A3 |
Notes | Application Number: TW20143130648 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160216&DB=EPODOC&CC=TW&NR=201605477A |
ParticipantIDs | epo_espacenet_TW201605477A |
PublicationCentury | 2000 |
PublicationDate | 20160216 |
PublicationDateYYYYMMDD | 2016-02-16 |
PublicationDate_xml | – month: 02 year: 2016 text: 20160216 day: 16 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | F. HOFFMANN-LA ROCHE AG |
RelatedCompanies_xml | – name: F. HOFFMANN-LA ROCHE AG |
Score | 3.1372173 |
Snippet | The invention provides combinations comprising a MEK inhibitor (such as GDC-0973 or GDC-0623), or a pharmaceutical ly acceptable salt thereof and an ERK... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160216&DB=EPODOC&locale=&CC=TW&NR=201605477A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNpzLnBxGkb0W7pu36MMS1HUPZB6NzextNm9L60I21IvjXe8m6jxd9CCQXEi6BX-4ud7kAPEaGHUZ6HKs217hKWzFVWzrjqoGqrG01aWTIaML-wOxN6NvMmFXgc_MWRuYJ_ZbJERFRIeK9kOf1cneJ5crYyvyJpUhavHT9tquU1rFmosgyFbfT9kZDd-gojtP2p8pgvO4zqGW9HsAhqtGWQIP30RGvUpb7IqV7BkcjnC0rzqHyk9TgxNn8vFaD437p8MZqib38AtJJzskiJgFBTtGelVyuCX3vnaRZkjKE54oEWYSFeON9IuqmZBtULkYlaICuluLPnpivs3-T0lmTX8JD1_Odnoo8z7cbNPenu-XpV1DNFhmvA4mZTk0q0m9rAQ2bLIhCnRksbD0HNlrF9jU0_p6n8V_nDZyKhohe1sxbqBarL36Hwrlg93JXfwHV55Vc |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaP4VROzt0XHuo09ECPbCAoDQob4RtatC_NhEDZj4l_vrYyPF31o0tylzbXJr3fXu14BHkLNDEI1imSTK1ymjYjKDZVxWUNT1jTqNNRENqHb1ztj-vahfZTgc_0WRtQJ_RbFERFRAeI9E-f1YnuJZYvcyvSRxUiaP7e9pi0V3rGio8rSJbvVdIYDe2BJltX0JlJ_tOJp1DBe9mAfTWwjR4Pz3spfpSx2VUr7GA6GOFuSnUDpZ1aFirX-ea0Kh24R8MZugb30FOJxysk8Ij5BSdGfFVKuCK7TJXEyixnCc0n8JMRGnNEuEW1Tskkqz0fN0AFdLvI_eyK-qv5NimBNegb3bcezOjLKPN1s0NSbbJennkM5mSf8AkjEVKrTvPy24tOgzvwwUJnGgsaTb6JXbF5C7e95av8x76DS8dzetPfa717BUc7IM5kV_RrK2fKL36Ciztit2OFfBCuYTw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+a+combination+of+a+MEK+inhibitor+and+an+ERK+inhibitor+for+treatment+of+hyperproliferative+diseases&rft.inventor=MOFFAT%2C+JOHN&rft.inventor=MERCHANT%2C+MARK&rft.inventor=BELVIN%2C+MARCIA&rft.date=2016-02-16&rft.externalDBID=A&rft.externalDocID=TW201605477A |